Dan H Barouch MD
Professor, Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School
Join to view full profile
330 Brookline AveResearch East 113 Beth Israel Deaconess HospitalBoston, MA 02215
Phone+1 617-667-4434
Fax+1 617-667-8210
Dr. Barouch is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts General Hospital/Brigham and Women's HospitalFellowship, Infectious Disease, 2001 - 2005
Harvard Medical SchoolClass of 2000
Certifications & Licensure
MA State Medical License 2001 - 2028
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Safety of and Immune Response to a DNA HIV Vaccine (VRC-HIVDNA009-00-VP) in HIV Infected Individuals With Acute HIV Infection
- Safety of and Immune Response to an Adenoviral HIV-1 Vaccine in Healthy Adults
- Safety and Immune Response to a Recombinant Adenovirus HIV-1 Vaccine in Healthy Adults Start of enrollment: 2009 Feb 08
Publications & Presentations
PubMed
- Distinct phases of immune system programming during ART-suppressed immunodeficiency virus infection.Maanasa Kaza, Benjamin Varco-Merth, G W McElfresh, Sebastian Benjamin, Gregory J Boggy
Cell Reports. 2026-10-27 - Early innate immune signatures correlate with Ad26.COV2.S vaccine immunogenicity and protective efficacy.Alessandro Colarusso, Kathryn E Stephenson, Ai-Ris Y Collier, Frank Wegmann, Roland Zahn
Journal of Virology. 2026-10-26 - Ionizable lipid impact on mRNA vaccine formulation properties and immunogenicity.Shahad K Alsaiari, Brendan Dyett, John Daristotle, Lisa H Tostanoski, Haitao Yu
Journal of Controlled Release. 2026-10-21
Journal Articles
- Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 VaccineJerald Sadoff, Kathryn E Stephenson, Dan H Barouch, Macaya Douoguih, The New England Journal of Medicine
Lectures
- 11th Vaccines Research and Development: All Things Considered ConferenceGlobal Technology Community (GTC), Boston, Massachusetts - 7/8/2013
- Publisher Correction: Antibody and TLR7 Agonist Delay Viral Rebound in SHIV-Infected MonkeysBeth Israel Deaconess Hospital - Needham , Harvard Medical School ,Department Of Continuing Educatio - 5/30/2013
Press Mentions
US Olympic Committee Remains ‘Dialed In’ To Prevent Spread of Stomach Illness at Winter GamesFebruary 10th, 2026- How Investing in Primary Care Helped a Hospital System Get Back in the BlackJanuary 25th, 2026
- Despite a Dip in Cases, Flu Remains at ‘Very High’ Levels in Mass., R.I., and N.HJanuary 13th, 2026
Grant Support
- Development of a Novel Trivalent Adjuvanted TB VaccineBETH ISRAEL DEACONESS MEDICAL CENTER2026–2031
- Multi-Omics Analysis of Broadly Neutralizing Antibodies and Therapeutic VaccinationBETH ISRAEL DEACONESS MEDICAL CENTER2023–2028
- I4C 2.0: Immunotherapy for CureBETH ISRAEL DEACONESS MEDICAL CENTER2021–2028
- HIV Vaccines Clinical Trials Network Leadership and Operations CenterFRED HUTCHINSON CANCER CENTER2025–2027
- Ad26 Based Therapeutic Vaccines for HIVBETH ISRAEL DEACONESS MEDICAL CENTER2020–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: